Bionano Genomics- Warrants (21/08/2023) PEG Ratio

Bionano Genomics- Warrants (21/08/2023) (BNGOW) currently reports a PEG ratio of -0.11. That is below the Healthcare sector average of 11.64. Use the charts on this page to explore Bionano Genomics- Warrants (21/08/2023)'s PEG ratio history and peer comparisons.

Bionano Genomics- Warrants (21/08/2023)'s PEG ratio of -0.11 is lower than the Healthcare sector average of 11.64. That is roughly 100.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Bionano Genomics- Warrants (21/08/2023)'s market price to a fundamental measure such as earnings, sales, or book value. At -0.11, BNGOW can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -0.11, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for Bionano Genomics- Warrants (21/08/2023), and consider following BNGOW for alerts when major investors trade the stock.

Bionano Genomics- Warrants (21/08/2023) is classified in the Healthcare sector. On PEG ratio, it currently shows -0.11 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNGOW with unrelated industries.